Kirkland Advised WindRose Health Investors on $2.6 Billion Fund VII

Kirkland Advised WindRose Health Investors on $2.6 Billion Fund VII

Kirkland & Ellis advised WindRose Health Investors, LLC, a New York-based healthcare private equity firm, on the formation of its seventh fund, WindRose Health Investors VII, L.P. (Fund VII), with $2.6 billion in limited partner and general partner commitments. The fund closed at its hard cap and significantly exceeded the size of Fund VI, its $1.4 billion predecessor fund. Fund VII expects to close on its first two acquisitions by year-end 2025 and is targeting 11-13 investments in total.

The Kirkland team included Sean Malone (Partner/ Investment Funds), Andrew Wright (Partner/ Investment Funds), Aura Gilham (Partner/ Investment Funds), Christine Lee (Associate/ Investment Funds), Danny Cundiff (Associate/ Investment Funds), Daisy An (Associate/ Investment Funds) and Muskan Sharma; Elie Zolty (Partner/ Tax), Claire Oxford (Associate/ Tax) and Daniella Wenger (Associate/ Tax) and Mac Laban (Partner/ Investment Funds).

If you have a news or deal publication or would like to collaborate on content, columns, or article publications, connect with the Legal Era News Network Team and email us at info@legalera.in or call us on +91 8879634922.